IP Library Granted Patent US 9,006,487
Granted Patent B2
US 9,006,487 · App. 11/453,222 · Granted Apr 14, 2015

Amine-containing lipids and uses thereof

Inventors: Daniel G. Anderson (Framingham, MA); Andreas Zumbuehl (Cambridge, MA); Elizaveta Sergeyevna Leshchiner (Turkhanova) (Watertown, MA); Robert S. Langer (Newton, MA); Michael Goldberg (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
A61K48/0033A61K9/1617C07C229/12C07C229/14C07C229/16C07C229/18C07C237/06C07D211/26C07D233/61C07D243/08C07D295/12C07D307/14C07D317/28C12N15/88
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,006,487
App. No.
11/453,222
Granted
Apr 14, 2015
Kind
B2
Abstract

Nitrogen-containing lipids prepared from the conjugate addition of amines to acrylates, acrylamides, or other carbon-carbon double bonds conjugated to electron-withdrawing groups are described. Methods of preparing these lipids from commercially available starting materials are also provided. These amine-containing lipids or salts forms of these lipids are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the amino moiety of these lipids, they are particularly suited for the delivery of polynucleotides. Complexes or nanoparticles containing the inventive lipid and polynucleotide have been prepared. The inventive lipids may also be used to in preparing microparticle for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.

Claims (64)

1. A compound of formula:

or a salt thereof;

wherein:

A is acyclic, substituted or unsubstituted, branched or unbranched aliphatic; or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic;

V is C═O;

R 1 is cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR A ; —SR A ; or —NHR A ; wherein each occurrence of R A is independently cyclic or acyclic, substituted or unsubstituted, branched or unbranched C 9 -C 16 aliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;

R 2 is cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR B ; —SR B ; or —NHR B ; wherein each occurrence of R B is independently cyclic or acyclic, substituted or unsubstituted, branched or unbranched C 9 -C 16 aliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;

R 3 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —SO 2 R C ; —NO 2 ; —N 3 ; —N(R C ) 2 ; —NHC(═O)R C ; —NR C C(═O)N(R C ) 2 ; —OC(═O)OR C ; —OC(═O)R C ; —OC(═O)N(R C ) 2 ; —NR C C(═O)OR C ; or —C(R C ) 3 ; wherein each occurrence of R C is independently a hydrogen; a protecting group; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted, heteroaryl; or —CH 2 CH 2 C(═O)R 1 ;

R 4 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR D ; —C(═O)R D ; —CO 2 R D ; —CN; —SCN; —SR D ; —SOR D ; —SO 2 R D ; —NO 2 ; —N 3 ; —N(R D ) 2 ; —NHC(═O)R D ; —NR C C(═O)N(R D ) 2 ; —OC(═O)OR D ; —OC(═O)R D ; —OC(═O)N(R D ) 2 ; —NR C C(═O)OR D ; or —C(R D ) 3 ; wherein each occurrence of R D is independently a hydrogen; a protecting group; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; or —CH 2 CH 2 C(═O)R 1 ;

wherein at least one of R 3 , R 4 , or R 7 is —CH 2 CH 2 C(═O)R 1 ;

each occurrence of R 5 is independently selected from the group consisting of hydrogen and C 1 -C 6 alkyl;

each occurrence of R 6 is independently selected from the group consisting of hydrogen and C 1 -C 6 alkyl;

R 7 is hydrogen; halogen; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR G ; —C(═O)R G ; —CO 2 R G ; —CN; —SCN; —SR G ; —SOR G ; —SO 2 R G ; —NO 2 ; —N 3 ; —N(R G ) 2 ; —NHC(═O)R G ; —NR G C(═O)N(R G ) 2 ; —OC(═O)OR G ; —OC(═O)R G ; —OC(═O)N(R G ) 2 ; —NR G C(═O)OR G ; or —CH 2 CH 2 C(═O)R 1 ; wherein each occurrence of R G is independently a hydrogen; a protecting group; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; an acyl moiety; alkoxy; aryloxy; alkylthio; arylthio; amino, alkylamino, dialkylamino, heteroaryloxy; or heteroarylthio moiety;

n is an integer between 1 and 10, inclusive; and

wherein each instance of substituted refers to the replacement of one, two, three, or more of the hydrogen atoms of an aliphatic, heteroaliphatic, aryl, or heteroaryl group with one, two, three, or more substituents independently selected from the group consisting of aliphatic; heteroaliphatic; aryl; heteroaryl; arylalkyl; heteroarylalkyl; alkoxy; aryloxy; heteroalkoxy; heteroaryloxy; alkylthio; arylthio; heteroalkylthio; heteroarylthio; —F; —Cl; —Br; —I; —OH; —NO 2 ; —CN; —CF 3 ; —CH 2 CF 3 ; —CHCl 2 ; —CH 2 OH; —CH 2 CH 2 OH; —CH 2 NH 2 ; —CH 2 SO 2 CH 3 ; —C(O)R x ; —CO 2 (R x ); —CO(O)R x ; —OCO 2 R x ; —OCON(R x ) 2 ; —N(R x ) 2 ; —N(R x ) 2 ; —S(O) 2 R x ; and —NR x (CO)R x , wherein each occurrence of R x independently is selected from the group consisting of aliphatic, heteroaliphatic, aryl, heteroaryl, arylalkyl, and heteroarylalkyl

and salts thereof.

2. The compound of claim 1 , wherein

is selected from the group consisting of:

3. A compound of formula:

or a salt thereof;

wherein:

each occurrence of x is an integer between 1 and 10, inclusive;

y is an integer between 1 and 10, inclusive;

each occurrence of R 7 is independently hydrogen or —CH 2 CH 2 C(═O)R 1 ;

wherein at least one of R 7 is —CH 2 CH 2 C(═O)R 1 ;

each occurrence of R 1 is independently cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR A ; —SR A ; or —NHR A ; wherein each occurrence of R A is independently cyclic or acyclic, substituted or unsubstituted, branched or unbranched C 9 -C 16 aliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;

wherein each instance of substituted refers to the replacement of one, two, three, or more of the hydrogen atoms of an aliphatic, heteroaliphatic, aryl, or heteroaryl group with one, two, three, or more substituents independently selected from the group consisting of aliphatic; heteroaliphatic; aryl; heteroaryl; arylalkyl; heteroarylalkyl; alkoxy; aryloxy; heteroalkoxy; heteroaryloxy; alkylthio; arylthio; heteroalkylthio; heteroarylthio; —F; —Cl; —Br; —I; —OH; —NO 2 ; —CN; —CF 3 ; —CH 2 CF 3 ; —CHCl 2 ; —CH 2 OH; —CH 2 CH 2 OH; —CH 2 NH 2 ; —CH 2 SO 2 CH 3 ; —C(O)R x ; —CO 2 (R x ); —OC(O)R x ; —OCO 2 R x ; —OCON(R x ) 2 ; —N(R x ) 2 ; —S(O) 2 R x ; and —NR x (CO)R x , wherein each occurrence of R x independently is selected from the group consisting of aliphatic, heteroaliphatic, aryl, heteroaryl, arylalkyl, and heteroarylalkyl.

4. The compound of claim 3 , wherein each occurrence of R 7 is independently selected from the group consisting of:

5. The compound of claim 3 , wherein each occurrence of R 7 is independently selected from the group consisting of:

6. The compound of claim 3 of the formula:

7. A compound of the formula:

or a salt thereof;

wherein:

A is acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic;

V is C═O;

R 1 is cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —SR A ; and —NHR A ; wherein each occurrence of R A is independently cyclic or acyclic, substituted or unsubstituted, branched or unbranched C 9 -C 16 aliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;

R 2 is cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —SR B ; or —NHR B ; wherein each occurrence of R B is independently a cyclic or acyclic, substituted or unsubstituted, branched or unbranched C 9 -C 16 aliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;

R 3 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —NO 2 ; —N 3 ; —N(R C ) 2 ; —NHC(═O)R C ; —NR C C(═O)N(R C ) 2 ; —OC(═O)OR C ; —OC(═O)R c ; —OC(═O)N(R C ) 2 ; —NR C C(═O)OR C ; or —C(R C ) 3 ; wherein each occurrence of R C is independently a hydrogen; a protecting group; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;

R 4 is hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR D ; —C(═O)R D ; —CO 2 R D ; —CN; —SCN; —SR D ; —SOR D ; —SO 2 R D ; —NO 2 ; —N 3 ; —N(R D ) 2 ; —NHC(═O)R D ; —NR C C(═O)N(R D ) 2 ; —OC(═O)OR D ; —OC(═O)R D ; —OC(═O)N(R D ) 2 ; —NR C C(═O)OR D ; or —C(R D ) 3 ; wherein each occurrence of R D is independently a hydrogen; a protecting group; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl;

provided that at least one of R 3 and R 4 is a substituted aliphatic;

wherein each instance of substituted refers to the replacement of one, two, three, or more of the hydrogen atoms of an aliphatic, heteroaliphatic, aryl, or heteroaryl group with one, two, three, or more substituents independently selected from the group consisting of aliphatic; heteroaliphatic; aryl; heteroaryl; arylalkyl; heteroarylalkyl; alkoxy; aryloxy; heteroalkoxy; heteroaryloxy; alkylthio; arylthio; heteroalkylthio; heteroarylthio; —F; —Cl; —Br; —I; —OH; —NO 2 ; —CN; —CF 3 ; —CH 2 CF 3 ; —CHCl 2 ; —CH 2 OH; —CH 2 CH 2 OH; —CH 2 NH 2 ; —CH 2 SO 2 CH 3 ; —C(O)R x ; —CO 2 (R x ); —OC(O)R x ; —OCO 2 R x ; —OCON(R x ) 2 ; —N(R x ) 2 ; —S(O) 2 R x ; and —NR x (CO)R x , wherein each occurrence of R x independently is selected from the group consisting of aliphatic, heteroaliphatic, aryl, heteroaryl, arylalkyl, and heteroarylalkyl.

8. The compound of claim 7 , wherein

is selected from the group consisting of:

9. The compound of claim 1 , wherein

are independently selected from the group consisting of:

10. The compound of claim 1 , wherein

are independently selected from the group consisting of:

11. The compound of claim 3 , wherein each occurrence of R 7 is independently selected from the group consisting of hydrogen,

12. The compound of claim 3 , wherein each occurrence of R 7 is independently selected from the group consisting of hydrogen,

13. The compound of claim 3 selected from the group consisting of:

wherein n is 8, 9, 10, 11, 12, 13, 14, or 15.

14. A composition comprising one or more compounds of claim 13 .

15. The compound according to claim 3 selected from the group consisting of:

wherein n is 8, 9, 10, 11, 12, 13, 14, or 15.

16. A composition comprising one or more compounds of claim 15 .

17. The compound of claim 13 selected from the group consisting of:

18. A composition comprising one or more compounds of claim 17 .

19. The composition of claim 14 or 16 further comprising an agent to be delivered.

20. The composition of claim 19 , wherein the agent is a polynucleotide, a protein, a peptide, or a small molecule.

21. The composition of claim 20 , wherein the agent is a polynucleotide.

22. The composition of claim 21 , wherein the polypeptide is DNA.

23. The composition of claim 21 , wherein the polypeptide is RNA.

24. The composition of claim 21 , wherein the polypeptide is siRNA, shRNA, antisense RNA, or a polypeptide encoding a protein or peptide.

25. The composition of claim 24 , wherein the polypeptide is a polypeptide encoding a protein or peptide.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 26, 2012
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029043/0129 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2006
From: ANDERSON, DANIEL G.; ZUMBUEHL, ANDREAS; LANGER, ROBERT S.; GOLDBERG, MICHAEL; LESHCHINER (TRUKHANOVA), ELIZAVETA SERGEYEVNA
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 018416/0925 →
Continuity (3)
Provisional Application 60690608 · Jun 15, 2005
Provisional Application 60785176 · Mar 23, 2006
Related Publication 20110009641A1 · Jan 13, 2011